Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
$49.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Acadia Healthcare Company Inc Lowers FY 2012 EPS Guidance


Tuesday, 31 Jul 2012 04:00pm EDT 

Acadia Healthcare Company Inc revised guidance for fiscal 2012 adjusted earnings per diluted share (EPS) to a range of $0.59 to $0.60 based upon the impact of the additional shares of common stock outstanding from the May public offering. The Company's previous guidance for fiscal 2012 adjusted EPS was a range of $0.65 to $0.67. The Company's guidance for adjusted EPS excludes transaction-related expenses and does not include the impact of any future acquisitions. According to I/B/E/S Estimates, analysts are expecting the Company to report EPS of $0.61 for fiscal 2012.